Jonathan Abrams
Harvard University
4 Papers
13 Citations
Jonathan Abrams is an academic researcher from Harvard University. The author has contributed to research in topics: Framingham Risk Score & Internal medicine. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Task force #1—identification of coronary heart disease risk: is there a detection gap?
Richard C. Pasternak,Jonathan Abrams,Philip Greenland,Lynn A Smaha,Peter W. F. Wilson,Nancy Houston-Miller +5 more
TL;DR: In contrast to the relative ease of recognition and clarity of treatment and prevention strategies in patients with symptomatic coronary heart disease, a major problem of detection, treatment, and prevention of CHD exists in the large population who have no symptoms of heart disease yet are at risk of disease.
223
(Committee on the Management of Patients With Chronic Stable Angina) Cardiology/American Heart Association Task Force on Practice Guidelines Stable Angina—Summary Article: A Report of the American College of ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic
Valentin Fuster,David P. Faxon,Gabriel Gregoratos,Alice K. Jacobs,Raymond J. Gibbons,Joseph S. Alpert,Elliott M. Antman,Julius M. Gardin,Richard C. Pasternak,John S. Douglas,T. Bruce Ferguson,Stephan D. Fihn,J. Gibbons,Jonathan Abrams,Kanu Chatterjee,Jennifer Daley +15 more
- 01 Jan 2008
13
Management of Patients With Chronic Stable Angina: A Report of the 2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the
Burden : Writing Group III High-Risk Patient for Primary Prevention : Noninvasive Tests of Atherosclerotic Prevention Conference V : Beyond Secondary Prevention : Identifying the
H. Jeremy Swan,Kathryn A. Taubert,Lewis Wexler,David M. Herrington,Lewis H. Kuller,Paul M. Ridker,William C. Roberts,Michael H. Criqui,John R. Crouse,Lawrence S. Friedman,Valentin Fuster,Philip Greenland,Jonathan Abrams,Gerard P. Aurigemma,M. Gene +14 more
- 01 Jan 2008
TL;DR: This paper presents a meta-analysis of the literature on noninvasive tests of Atherosclerotic Prevention at Conference V of Beyond Secondary Prevention to identify the high-risk patients and how these patients are selected for prevention.